Back

Investigation of a Pathogenic Inversion in UNC13D and Comprehensive Analysis of Chromosomal Inversions Across Diverse Datasets

Bozkurt-Yozgatli, T.; Lun, M. Y.; Bengtsson, J. D.; Sezerman, U.; Chinn, I. K.; Coban-Akdemir, Z.; Carvalho, C. M. B.

2024-10-29 genetic and genomic medicine
10.1101/2024.10.28.24315942 medRxiv
Show abstract

Inversions are known contributors to the pathogenesis of genetic diseases. Identifying inversions poses significant challenges, making it one of the most demanding structural variants (SVs) to detect and interpret. Recent advancements in sequencing technologies and the development of publicly available SV datasets have substantially enhanced our capability to explore inversions. However, a cross-comparison in those datasets remains unexplored. In this study, we reported a proband with familial hemophagocytic lymphohistiocytosis type-3 carrying c.1389+1G>A in trans with NC_000017.11:75576992_75829587inv disrupting UNC13D, an inversion present in 0.006345% of individuals in gnomAD(v4.0). Based on this result, we investigate the features of potentially pathogenic inversions in public datasets. 98.9% of inversions are rare in gnomAD, and they disrupt 5% of protein-coding genes associated with a phenotype in OMIM. We then conducted a comparative analysis of the datasets, including gnomAD, DGV, and 1KGP, and two recent studies from the Human Genome Structural Variation Consortium revealed common and dataset-specific inversion characteristics suggesting methodology detection biases. Next, we investigated the genetic features of inversions disrupting the protein-coding genes by classifying the intersections between them into three categories. We found that most of the protein-coding genes in OMIM disrupted by inversions are associated with autosomal recessive phenotypes regardless of categories supporting the hypothesis that inversions in trans with other variants are hidden causes of monogenic diseases. This effort aims to fill the gap in our understanding of the molecular characteristics of inversions with low frequency in the population and highlight the importance of identifying them in rare disease studies.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Frontiers in Genetics
197 papers in training set
Top 0.1%
33.6%
2
Human Mutation
29 papers in training set
Top 0.1%
6.9%
3
Human Genetics
25 papers in training set
Top 0.1%
4.0%
4
The American Journal of Human Genetics
206 papers in training set
Top 1%
4.0%
5
Scientific Reports
3102 papers in training set
Top 35%
3.7%
50% of probability mass above
6
Human Genetics and Genomics Advances
70 papers in training set
Top 0.1%
3.7%
7
BMC Medical Genomics
36 papers in training set
Top 0.1%
3.7%
8
Journal of Clinical Immunology
11 papers in training set
Top 0.1%
2.6%
9
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.2%
2.4%
10
Human Molecular Genetics
130 papers in training set
Top 1%
1.8%
11
BMC Genomic Data
12 papers in training set
Top 0.1%
1.7%
12
PLOS Genetics
756 papers in training set
Top 8%
1.7%
13
American Journal of Medical Genetics Part A
17 papers in training set
Top 0.2%
1.7%
14
Human Genomics
21 papers in training set
Top 0.1%
1.5%
15
Frontiers in Immunology
586 papers in training set
Top 5%
1.2%
16
The Journal of Molecular Diagnostics
36 papers in training set
Top 0.3%
1.0%
17
International Journal of Molecular Sciences
453 papers in training set
Top 12%
0.9%
18
Genome Medicine
154 papers in training set
Top 7%
0.9%
19
European Journal of Human Genetics
49 papers in training set
Top 1%
0.9%
20
Genetics in Medicine
69 papers in training set
Top 0.9%
0.9%
21
BMC Genomics
328 papers in training set
Top 5%
0.8%
22
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 8%
0.8%
23
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 5%
0.8%
24
Genetics in Medicine Open
10 papers in training set
Top 0.1%
0.8%
25
Journal of Personalized Medicine
28 papers in training set
Top 1%
0.8%
26
Cell Genomics
162 papers in training set
Top 6%
0.8%
27
npj Genomic Medicine
33 papers in training set
Top 0.9%
0.8%
28
Frontiers in Human Neuroscience
67 papers in training set
Top 2%
0.8%
29
Genomics
60 papers in training set
Top 3%
0.7%
30
Frontiers in Oncology
95 papers in training set
Top 4%
0.7%